OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.345
+0.025 (1.08%)
At close: Jul 8, 2026, 4:00 PM EDT
2.220
-0.125 (-5.33%)
After-hours: Jul 8, 2026, 7:58 PM EDT
OmniAb Market Cap
OmniAb has a market cap or net worth of $333.44 million as of July 8, 2026. Its market cap has increased by 69.29% in one year.
Market Cap
333.44M
Enterprise Value
304.03M
1-Year Change
69.29%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $333.44M, a decrease of -66.42%. That is a compound annual growth rate of -25.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 333.44M | 25.20% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 371.69M |
| Lexeo Therapeutics | 368.27M |
| Abeona Therapeutics | 364.77M |
| Palisade Bio | 364.52M |
| Opus Genetics | 344.30M |
| Indaptus Therapeutics | 343.12M |
| Fate Therapeutics | 340.35M |
| Larimar Therapeutics | 340.29M |